REDD2-mediated inhibition of mTOR promotes dendrite retraction induced by axonal injury

Cell Death and Differentiation

Volumn 22, Issue 4, 2015, Pages 612-625

  Morquette, B ^a,b   Morquette, P ^a,b   Agostinone, J ^a,b   Feinstein, E ^c   McKinney, R A ^d   Kolta, A ^a,b   Di Polo, A ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c QBI Enterprises Ltd   (Israel)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN; PROTEIN S6; REGULATED IN DEVELOPMENT AND DNA DAMAGE RESPONSE 2 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT; MTOR PROTEIN, MOUSE; RAPAMYCIN; REDD2 PROTEIN, MOUSE; TARGET OF RAPAMYCIN KINASE; THY 1 ANTIGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CELL DEATH; CELL POPULATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DENDRITE; GENE SILENCING; MALE; MOUSE; NERVE CELL; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE FIBER TRANSECTION; NONHUMAN; OPTIC NERVE INJURY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RETINA CELL; RETINA GANGLION CELL; UPREGULATION; WHOLE CELL PATCH CLAMP; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; NERVE FIBER; PATCH CLAMP TECHNIQUE; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, THY-1; APOPTOSIS; AXONS; DENDRITES; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, TRANSGENIC; OPTIC NERVE INJURIES; PATCH-CLAMP TECHNIQUES; PROTEINS; RETINAL GANGLION CELLS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIROLIMUS; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84925500093     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.149     Document Type: Article

References (73)

1. Luo L, O'Leary DDM. Axon retraction and degeneration in development and disease. Ann Rev Neurosci 2005; 28: 127-156.
2. Cheng P-l, Poo M-m. Early events in axon/dendrite polarization. Ann Rev Neurosci 2012; 35: 181-201.
3. Wong RO, Ghosh A. Activity-dependent regulation of dendritic growth and patterning. Nat Rev Neurosci 2002; 3: 803-812.
4. Lin Y-C, Koleske AJ. Mechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disorders. Ann Rev Neurosci 2010; 33: 349-378.
5. Liu M, Duggan J, Salt TE, Cordeiro MF. Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions. Exp Eye Res 2011; 92: 244-250.
6. Jaworski J, Spangler S, Seeburg DP, Hoogenraad CC, Sheng M. Control of dendritic arborization by the phosphoinositide-3′-Kinase-Akt-mammalian target of rapamycin pathway. J Neurosci 2005; 25: 11300-11312.
7. Kumar V, Zhang M-X, Swank MW, Kunz J, Wu G-Y. Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 2005; 25: 11288-11299.
8. Gao X, Neufeld TP, Pan D. Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways. Dev Biol 2000; 221: 404-418.
9. Kwon C-H, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 2006; 50: 377-388.
10. Hoeffer CA, Klann E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 2010; 33: 67-75.
11. Li N, Lee B, Liu R-J, Banasr M, Dwyer JM, Iwata M et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010; 329: 959-964.
12. Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004; 18: 2893-2904.
13. Corradetti MN, Inoki K, Guan K-L. The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J Biol Chem 2005; 280: 9769-9772.
14. Sofer A, Lei K, Johannessen CM, Ellisen LW. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol 2005; 25: 5834-5845.
15. Imen JS, Billiet L, Cuaz-Pérolin C, Michaud N, Rouis M. The regulated in development and DNA damage response 2 (REDD2) gene mediates human monocyte cell death through a reduction in thioredoxin-1 expression. Free Radic Biol Med 2009; 46: 1404-1410.
16. Cuaz-Pérolin C, Furman C, Larigauderie G, Legedz L, Lasselin C, Copin C et al. REDD2 gene is upregulated by modified LDL or hypoxia and mediates human macrophage cell death. Arterioscler Thromb Vasc Biol 2004; 24: 1830-1835.
17. Miyazaki M, Esser KA. REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch. Am J Phys 2009; 296: C583-C592.
18. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000; 28: 41-51.
19. Galindo-Romero C, Avilés-Trigueros M, Jiménez-López M, Valiente-Soriano FJ, Salinas-Navarro M, Nadal-Nicolás F et al. Axotomy-induced retinal ganglion cell death in adult mice: quantitative and topographic time course analyses. Exp Eye Res 2011; 92: 377-387.
20. Sun W, Li N, He S. Large-scale morphological survey of mouse retinal ganglion cells. J Comp Neurol 2002; 451: 115-126.
21. Coombs J, van der List D, Wang GY, Chalupa LM. Morphological properties of mouse retinal ganglion cells. Neuroscience 2006; 140: 123-136.
22. Jefferies HBJ, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G. Rapamycin suppresses 5[prime]TOP mRNA translation through inhibition of p70s6k. EMBO J 1997; 16: 3693-3704.
23. Ikenoue T, Hong S, Inoki K. Monitoring mammalian target of rapamycin (mTOR) activity. Methods Enzymol 2009; 452: 165-180.
24. Cui Q, Yip HK, Zhao RC, So KF, Harvey AR. Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons. Mol Cell Neurosci 2003; 22: 49-61.
25. Yin Y, Cui Q, Li Y, Irwin N, Fischer D, Harvey AR et al. Macrophage-derived factors stimulate optic nerve regeneration. J Neurosci 2003; 23: 2284-2293.
26. DeYoung MP, Horak P, Sofer A, Sgroi D, Ellisen LW. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 2008; 22: 239-251.
27. Reiling JH, Hafen E. The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila. Genes Dev 2004; 18: 2879-2892.
28. Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S et al. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 2002; 22: 2283-2293.
29. del Olmo-Aguado S, Núñez-Álvarez C, Ji D, Manso AG, Osborne NN. RTP801 immunoreactivity in retinal ganglion cells and its down-regulation in cultured cells protect them from light and cobalt chloride. Brain Res Bull 2013; 98: 132-144.
30. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 1992; 69: 1227-1236.
31. Janssen KT, Mac Nair CE, Dietz JA, Schlamp CL, Nickells RW. Nuclear atrophy of retinal ganglion cells precedes the Bax-dependent stage of apoptosis. Invest Ophthalmol Vis Sci. 2013; 54: 1805-1815.
32. Kwon C-H, Zhu X, Zhang J, Baker SJ. mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proc Natl Acad Sci USA 2003; 100: 12923-12928.
33. Wong WT, Wong ROL. Rapid dendritic movements during synapse formation and rearrangement. Curr Opin Neurobiol 2000; 10: 118-124.
34. Cline HT. Dendritic arbor development and synaptogenesis. Curr Opin Neurobiol 2001; 11: 118-126.
35. Koleske AJ. Molecular mechanisms of dendrite stability. Nat Rev Neurosci 2013; 14: 536-550.
36. Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog Ret Eye Res 2012; 31: 152-181.
37. Morgan JE, Datta AV, Erichse nJT, Albon J, Boulton ME. Retinal ganglion cell remodelling in experimental glaucoma. Adv Exp Med Biol 2006; 572: 397-402.
38. Shou T, Liu J, Wang W, Zhou Y, Zhao K. Differential dendritic shrinkage of alpha and beta retinal ganglion cells in cats with chronic glaucoma. Invest Ophthalmol Vis Sci 2003; 44: 3005-3010.
39. Weber AJ, Kaufman PL, Hubbard WC. Morphology of single ganglion cells in the glaucomatous primate retina. Invest Ophthalmol Vis Sci 1998; 39: 2304-2320.
40. Li Z-w, Liu S, Weinreb RN, Lindsey JD, Yu M, Liu L et al. Tracking dendritic shrinkage of retinal ganglion cells after acute elevation of intraocular pressure. Invest Ophthalmol Vis Sci 2011; 52: 7205-7212.
41. Williams PA, Howell GR, Barbay JM, Braine CE, Sousa GL, John SWM et al. Retinal ganglion cell dendritic atrophy in DBA/2J glaucoma. PLoS One 2013; 8: e72282.
42. Della Santina L, Inman DM, Lupien CB, Horner PJ, Wong ROL. Differential progression of structural and functional alterations in distinct retinal ganglion cell types in a mouse model of glaucoma. J Neurosci 2013; 33: 17444-17457.
43. Feng L, Zhao Y, Yoshida M, Chen H, Yang JF, Kim TS et al. Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location. Invest Ophthalmol Vis Sci 2013; 54: 1106-1117.
44. Pavlidis M, Stupp T, Naskar R, Cengiz C, Thanos S. Retinal ganglion cells resistant to advanced glaucoma: A Postmortem Study of Human Retinas with the Carbocyanine Dye Dil. Invest Ophthalmol Vis Sci 2003; 44: 5196-5205.
45. Nickells RW, Howell GR, Soto I, John SWM. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Ann Rev Neurosci 2012; 35: 153-179.
46. Kalesnykas G, Oglesby EN, Zack DJ, Cone FE, Steinhart MR, Tian J et al. Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma. Invest Ophthalmol Vis Sci 2012; 53: 3847-3857.
47. Leung CK-s, Weinreb RN, Li ZW, Liu S, Lindsey JD, Choi N et al. Long-term in vivo imaging and measurement of dendritic shrinkage of retinal ganglion cells. Invest Ophthalmol Vis Sci 2011; 52: 1539-1547.
48. Lin B, Wang SW, Masland RH. Retinal ganglion cell type, size, and spacing can be specified independent of homotypic dendritic contacts. Neuron 2004; 43: 475-485.
49. Kim I-J, Zhang Y, Yamagata M, Meister M, Sanes JR. Molecular identification of a retinal cell type that responds to upward motion. Nature 2008; 452: 478-482.
50. Weber AJ, Harman CD. BDNF preserves the dendritic morphology of α and β ganglion cells in the cat retina after optic nerve injury. Invest Ophthalmol Vis Sci 2008; 49: 2456-2463.
51. Ortells MC, Morancho B, Drews-Elger K, Viollet B, Laderoute KR, López-Rodríguez C et al. Transcriptional regulation of gene expression during osmotic stress responses by the mammalian target of rapamycin. Nucleic Acids Res 2012; 40: 4368-4384.
52. Ergorul C, Ray A, Huang W, Wang D, Ben Y, Cantuti-Castelvetri I et al. Hypoxia inducible factor-1α (HIF-1α) and some HIF-1 target genes are elevated in experimental glaucoma. J Mol Neurosci 2010; 42: 183-191.
53. Kanamori A, Catrinescu M-M, Kanamori N, Mears KA, Beaubien R, Levin LA. Superoxide is an associated signal for apoptosis in axonal injury. Brain 2010; 133: 2612-2625.
54. Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008; 322: 963-966.
55. Park KK, Liu K, Hu Y, Kanter JL, He Z. PTEN/mTOR and axon regeneration. Exp Neurol 2010; 223: 45-50.
56. Morgan-Warren PJ, Berry M, Ahmed Z, Scott RAH, Logan A. Exploiting mTOR signaling: a novel translatable treatment strategy for traumatic optic neuropathy? Invest Ophthalmol Vis Sci 2013; 54: 6903-6916.
57. Kurimoto T, Yin Y, Omura K, Gilbert H-y, Kim D, Cen L-P et al. Long-distance axon regeneration in the mature optic nerve: contributions of oncomodulin, cAMP, and pten gene deletion. J Neurosci 2010; 30: 15654-15663.
58. Leibinger M, Andreadaki A, Fischer D. Role of mTOR in neuroprotection and axon regeneration after inflammatory stimulation. Neurobiol Dis. 2012; 46: 314-324.
59. Swiech L, Blazejczyk M, Urbanska M, Pietruszka P, Dortland BR, Malik AR et al. CLIP-170 and IQGAP1 cooperatively regulate dendrite morphology. J Neurosci 2011; 31: 4555-4568.
60. Malik AR, Urbanska M, Macias M, Skalecka A, Jaworski J. Beyond control of protein translation: What we have learned about the non-canonical regulation and function of mammalian target of rapamycin (mTOR). Biochim Biophys Acta 2013; 1834: 1434-1448.
61. Ward NJ, Ho KW, Lambert WS, Weitlauf C, Calkins DJ. Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection. J Neurosci 2014; 34: 3161-3170.
62. Raab-Graham KF, Haddick PCG, Jan YN, Jan LY. Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites. Science 2006; 314: 144-148.
63. Cudmore RH, Fronzaroli-Molinieres L, Giraud P, Debanne D. Spike-time precision and network synchrony are controlled by the homeostatic regulation of the D-type potassium current. J Neurosci 2010; 30: 12885-12895.
64. Metz AE, Spruston N, Martina M. Dendritic D-type potassium currents inhibit the spike afterdepolarization in rat hippocampal CA1 pyramidal neurons. J Physiol 2007; 581: 175-187.
65. Bateup Helen S, Johnson Caroline A, Denefrio Cassandra L, Saulnier Jessica L, Kornacker K, Sabatini Bernardo L. Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron 2013; 78: 510-522.
66. Lebrun-Julien F, Morquette B, Douillette A, Saragovi HU, Di Polo A. Inhibition of p75NTR in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Mol Cell Neurosci 2009; 40: 410-420.
67. Lebrun-Julien F, Duplan L, Pernet V, Osswald IK, Sapieha P, Bourgeois P et al. Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism. J Neurosci 2009; 29: 5536-5545.
68. Nadal-Nicolás FM, Jiménez-López M, Sobrado-Calvo P, Nieto-López L, Cánovas-Martínez I, Salinas-Navarro M et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naïve and optic nerve-injured retinas. Invest Ophthalmol Vis Sci 2009; 50: 3860-3868.
69. Czauderna F, Fechtner M, Dames S, Aygun H, Klippel A, Pronk GJ et al. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 2003; 31: 2705-2716.
70. Leon S, Yin Y, Nguyen J, Irwin N, Benowitz LI. Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci 2000; 20: 4615-4626.
71. Mansour-Robaey S, Clarke DB, Wang Y-C, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA 1994; 91: 1632-1636.
72. Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M et al. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 2008; 28: 5422-5432.
73. Schmidt TM, Kofuji P. An isolated retinal preparation to record light response from genetically labeled retinal ganglion cells. J Vis Exp 2011; 47: 2367.